Hoth Therapeutics, Inc. (HOTH)
Largest Insider Buys in Sector
HOTH Stock Price History Chart
HOTH Stock Performance
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory …
Insider Activity of Hoth Therapeutics, Inc.
Over the last 12 months, insiders at Hoth Therapeutics, Inc. have bought $16,750 and sold $0 worth of Hoth Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Hoth Therapeutics, Inc. have bought $16,750 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Knie Robb (CEO and President) — $16,750.
The last purchase of 25,000 shares for transaction amount of $16,750 was made by Knie Robb (CEO and President) on 2024‑08‑16.
List of Insider Buy and Sell Transactions, Hoth Therapeutics, Inc.
| 2024-08-16 | CEO and President | 25,000 0.5041% | $0.67 | $16,750 | +12.66% | |||
| 2020-05-26 | Sale | 0 – | $0 | $0 | -25.09% |